Top San Diego, CA Pharmaceutical Startups (69)
Trialfacts was established in 2006 to provide specialised patient recruitment services and effective solutions to the clinical trial industry. Trialfacts combines it’s extensive marketing and advertising expertise with in-depth clinical trial experience to create effective marketing solutions that adhere to GCP and HREC requirements. If you’d like to learn more please visit https://trialfacts.com/participantsguaranteed
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Our pipeline includes tipifarnib, a farnesyl...
Crinetics is a pharmaceutical company that develops much-needed therapies for people with rare endocrine diseases. We’re here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure we’re solving real problems for them. And we build value in the company for investors by filling...
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have...
Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families better protection from severe allergic reactions. We are developing a product that patients and their caregivers can use without anxiety or hesitation, confident in the effectiveness of the both product and the ability to administer it. We are developing ARS-1, a novel intranasal epinephrine spray with a unique...
Rancho BioSciences is an international fee for service data curation company with analysis and developer services. Our customers include Pharma, Foundations, Government and Biotech. We have a team of experienced PhD and PhD/MD scientists around the world that deliver high quality work based on their expertise and domain knowledge in biology, diseases and clinical data. Rancho BioSciences is flexible and cost...
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Working to solve complex problems in taste receptor biology and employ new therapeutic modalities to treating eating disorders and obesity.
ImprimisRx, based in San Diego, California, is a specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations. We are a rapidly growing company looking to add talented individuals to join our team to help us reach our goals. We have a unique business model and a dedicated group of extraordinary people...
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
Rempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance.
A pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins.
Polaris Pharmaceuticals is a multinational biotechnology company focused on developing novel anti-cancer therapies.
PersImmune is a clinical-stage immunotherapy company whose mission is to provide cancer patients with optimized immunotherapy.
BioBlocks is a medicinal research organization that provides medicinal chemistry services and products to pharmaceutical customers.
Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ovarian cancer (PROC). Azenosertib is being evaluated as a monotherapy and in combination across multiple tumor types in clinical trials and has broad franchise potential. In clinical trials, azenosertib has been well tolerated and has demonstrated...
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.
